Works matching IS 01145916 AND DT 2020 AND VI 43 AND IP 12

Results: 13

Renin–Angiotensin–Aldosterone System Inhibitors and Risk of Death in Patients Hospitalised with COVID-19: A Retrospective Italian Cohort Study of 43,000 Patients.

Published in:

Drug Safety, 2020, v. 43, n. 12, p. 1297, doi. 10.1007/s40264-020-00994-5

By:

Trifirò, Gianluca;
Massari, Marco;
Da Cas, Roberto;
Menniti Ippolito, Francesca;
Sultana, Janet;
Crisafulli, Salvatore;
Giorgi Rossi, Paolo;
Marino, Massimiliano;
Zorzi, Manuel;
Bovo, Emanuela;
Leoni, Olivia;
Ludergnani, Monica;
Spila Alegiani, Stefania;
ITA-COVID-19: RAAS inhibitor group;
Traversa, Giuseppe;
Onder, Graziano;
Ientile, Valentina;
Grilli, Roberto;
Formoso, Giulio;
Vicentini, Massimo

Publication type:

Article

Post-Marketing Safety Surveillance for the Adjuvanted Recombinant Zoster Vaccine: Methodology.

Published in:

Drug Safety, 2020, v. 43, n. 12, p. 1223, doi. 10.1007/s40264-020-00989-2

By:

Tavares-Da-Silva, Fernanda;
Mahaux, Olivia;
Van Holle, Lionel;
Haguinet, François;
Seifert, Harry;
Stegmann, Jens-Ulrich

Publication type:

Article

Temelimab, an IgG4 Anti-Human Endogenous Retrovirus Monoclonal Antibody: An Early Development Safety Review.

Published in:

Drug Safety, 2020, v. 43, n. 12, p. 1287, doi. 10.1007/s40264-020-00988-3

By:

Kornmann, Gabrielle;
Curtin, François

Publication type:

Article

Current Evidence on Abuse and Misuse of Gabapentinoids.

Published in:

Drug Safety, 2020, v. 43, n. 12, p. 1235, doi. 10.1007/s40264-020-00985-6

By:

Hägg, Staffan;
Jönsson, Anna K.;
Ahlner, Johan

Publication type:

Article

Ipilimumab-Induced Enterocolitis: A Systematic Review and Meta-Analysis.

Published in:

2020

By:

Witges, Kelcie;
Shafer, Leigh Anne;
Zarychanski, Ryan;
Abou-Setta, Ahmed M.;
Rabbani, Rasheda;
Dingwall, Orvie;
Bernstein, Charles N.

Publication type:

journal article

Liver Injury with Ulipristal Acetate: Exploring the Underlying Pharmacological Basis.

Published in:

Drug Safety, 2020, v. 43, n. 12, p. 1277, doi. 10.1007/s40264-020-00975-8

By:

Gatti, Milo;
Poluzzi, Elisabetta;
De Ponti, Fabrizio;
Raschi, Emanuel

Publication type:

Article

An Evaluation of Postmarketing Reports of Serious Idiosyncratic Liver Injury Associated with Ulipristal Acetate for the Treatment of Uterine Fibroids.

Published in:

Drug Safety, 2020, v. 43, n. 12, p. 1267, doi. 10.1007/s40264-020-00960-1

By:

Kang, Sarah;
Brinker, Allen;
Jones, S. Christopher;
Dimick-Santos, Lara;
Avigan, Mark I.

Publication type:

Article

Acknowledgement to Referees.

Published in:: Drug Safety, 2020, v. 43, n. 12, p. 1195, doi. 10.1007/s40264-020-01019-x
Publication type:: Article

Psychiatric Disorders and Hydroxychloroquine for Coronavirus Disease 2019 (COVID-19): A VigiBase Study.

Published in:

Drug Safety, 2020, v. 43, n. 12, p. 1315, doi. 10.1007/s40264-020-01013-3

By:

Garcia, Philippe;
Revet, Alexis;
Yrondi, Antoine;
Rousseau, Vanessa;
Degboe, Yannick;
Montastruc, François

Publication type:

Article

Potential Safety Issues with Use of Sodium-Glucose Cotransporter 2 Inhibitors, Particularly in People with Type 2 Diabetes and Chronic Kidney Disease.

Published in:

Drug Safety, 2020, v. 43, n. 12, p. 1211, doi. 10.1007/s40264-020-01010-6

By:

Milder, Tamara Y.;
Stocker, Sophie L.;
Day, Richard O.;
Greenfield, Jerry R.

Publication type:

Article

Liver Injury Associated with the Selective Progesterone Modulator Ulipristal.

Published in:

2020

By:

Björnsson, Einar S.

Publication type:

Letter

Assessing the Safety of COVID-19 Vaccines: A Primer.

Published in:

Drug Safety, 2020, v. 43, n. 12, p. 1205, doi. 10.1007/s40264-020-01002-6

By:

Petousis-Harris, Helen

Publication type:

Article

Sex Differences in Reported Adverse Drug Reactions to COVID-19 Drugs in a Global Database of Individual Case Safety Reports.

Published in:

Drug Safety, 2020, v. 43, n. 12, p. 1309, doi. 10.1007/s40264-020-01000-8

By:

Zekarias, Alem;
Watson, Sarah;
Vidlin, Sara Hedfors;
Grundmark, Birgitta

Publication type:

Article